TY  - JOUR
AU  - Tatsch, Klaus
AU  - Buchert, Ralph
AU  - Bartenstein, Peter
AU  - Barthel, Henryk
AU  - Boecker, Henning
AU  - Brust, Peter
AU  - Drzezga, Alexander
AU  - la Fougère, Christian
AU  - Gründer, Gerhard
AU  - Grünwald, Frank
AU  - Krause, Bernd-J.
AU  - Kuwert, Torsten
AU  - Langen, Karl-Josef
AU  - Rominger, Axel
AU  - Sabri, Osama
AU  - Schreckenberger, Mathias
AU  - Meyer, Philipp T.
TI  - SPECT-Untersuchungen mit dem 123I-markierten Dopamintransporter-Liganden FP-CIT (DaTSCANTM)
JO  - Nuklearmedizin
VL  - 58
IS  - 01
SN  - 2567-6407
CY  - Stuttgart
PB  - Thieme
M1  - FZJ-2019-02118
SP  - 5 - 16
PY  - 2019
AB  - The aim of the S1 guideline is to assist in establishing the indication and in performing, interpreting and reporting SPECT investigations of the dopamine transporter (DAT) with DaTSCANTM. Compared to the preceding version dated from 2007 the current update considers relevant new publications, the guidelines of the European (EANM) and Society of Nuclear Medicine (SNM), and the current version of the S3 guideline of the German Society of Neurology on „Idiopathic Parkinsonsian Syndrome“. In addition new technical developments are incorporated.
LB  - PUB:(DE-HGF)16
C6  - pmid:30769368
UR  - <Go to ISI:>//WOS:000459505900001
DO  - DOI:10.1055/a-0807-8137
UR  - https://juser.fz-juelich.de/record/861681
ER  -